Discover the future of Cystic Fibrosis in this RESP seminar.
Recorded Wednesday 2 July 2025
This insightful and educational session is part of the RESP (Respiratory Expert Speaker and Patient) webinar series, proudly presented by Respiratory Futures, INSPIRE and Asthma + Lung UK.
This webinar featured expert speaker Dr Charlotte Addy and a patient representative.
This webinar is RCP CPD approved (code: 151139) for those who join the live webinar and complete the feedback form provided. Please note: Application for CPD approval has been submitted to the Federation of the Royal Colleges of Physicians of the UK.
Dr Charlotte Addy
A self confessed Sputumologist, Dr Charlotte Addy is a respiratory physician and Clinical Senior Lecturer based in Cardiff, with specialist interests in Cystic Fibrosis (CF) and Bronchiectasis. She has research interests in lung infection, inflammation and biomarkers. She is part of the CF Trust Clinical Trials accelerator Programme and European CF Society Clinical Trials Network (ECFS-CTN). She is co-chairing the CF Trust Antimicrobial guideline group, sits on the ECFS Standards of Care Committee and helped write the recent ECFS standards of care.
She also has keen interests in service development, education, training and workforce planning and is TPD for South Wales. She has held a number of BTS posts across multiple committees and is a current member of the BTS Council.
Patient Representative
Sophie Pierce is a Person with Cystic Fibrosis. She is a social worker, a trustee of the Cystic Fibrosis Trust and the first person with CF to row the Atlantic.
Mesothelioma is a rare type of lung cancer, typically caused by Asbestos inhalation and commonly...
The GIRFT Tuberculosis (TB) report is a comprehensive, data-driven national review of TB services...
In 2020 the COVID-19 pandemic hit the global population, causing lockdowns and economic...
This guideline covers diagnosing, assessing, and treating community-acquired and hospital-acquired...
COPD is the second most common cause for hospital admission and the third leading cause of death...